Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss

被引：0
|
作者：
E W Iepsen
J Lundgren
C Dirksen
J-EB Jensen
O Pedersen
T Hansen
S Madsbad
J J Holst
S S Torekov
机构：
[1] Faculty of Health Sciences,Department of Biomedical Sciences and NNF Center for Basic Metabolic Research
[2] University of Copenhagen,Department of Endocrinology
[3] Hvidovre University Hospital,undefined
来源：
International Journal of Obesity | 2015年 / 39卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：834 / 841
页数：7
相关论文
共 50 条
  • [31] Elucidating the Role of Weight Loss and Glycemia with Observed Benefits of GLP-1 Receptor Agonist Treatment in Patients with T2D
    Sharma, Anukriti
    Mariam, Arshiya
    Zacherle, Emily
    Milinovich, Alex
    Bauman, Janine
    Sugano, David S.
    Noone, Joshua
    Rajpura, Jigar R.
    Zimmerman, Robert S.
    Burguera, Barto
    Kattan, Michael
    Misra-Hebert, Anita D.
    Pantalone, Kevin M.
    Rotroff, Daniel M.
    DIABETES, 2023, 72
  • [32] An uncommun digestive event under treatment with GLP-1 receptor agonist
    Hadjadj, P.
    Campredon, P.
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2020, 24 (4-5): : 166 - 167
  • [33] AVE-0010 GLP-1 Receptor Agonist Treatment of Diabetes
    Campas, C.
    Castaner, R.
    DRUGS OF THE FUTURE, 2008, 33 (10) : 838 - 840
  • [34] GIP Receptor Agonism Enhances Weight Loss from Either a Biased or an Unbiased GLP-1 Receptor Agonist in DIO Mice
    Coghlan, Matthew P.
    O'Farrell, Libbey
    Showalter, Aaron D.
    Wainscott, David B.
    Stutsman, Cynthia
    Cardona, Guemalli
    Cabrera, Over
    Alsina-Fernandez, Jorge
    Willard, Francis S.
    Sloop, Kyle
    Coskun, Tamer
    DIABETES, 2021, 70
  • [35] Obesity/Type 2 diabetes: GLP-1 agonist tirzepatide promotes weight loss
    Simon, Annika
    DIABETOLOGIE UND STOFFWECHSEL, 2024, 19 (01) : 27 - 28
  • [36] Obesity/Type 2 diabetes: GLP-1 agonist tirzepatide promotes weight loss
    Simon, Annika
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2024, 149 (08) : 416 - 416
  • [37] Beyond Weight Loss: Evaluating Cardiovascular Advantages of GLP-1 Receptor Agonists
    Vezza, Teresa
    Victor, Victor M.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2024, : 505 - 507
  • [38] GLP-1 receptor agonists: Nonglycemic clinical effects in weight loss and beyond
    Ryan, Donna
    Acosta, Andres
    OBESITY, 2015, 23 (06) : 1119 - 1129
  • [39] GLP-1 receptor agonists and weight loss in schizophrenia - past, present, and future
    Trott, Mike
    Arnautovska, Urska
    Siskind, Dan
    CURRENT OPINION IN PSYCHIATRY, 2024, 37 (05) : 363 - 369
  • [40] Exenatide.: Treatment of type 2 diabetes GLP-1 receptor agonist
    McIntyre, JA
    Bayés, M
    DRUGS OF THE FUTURE, 2004, 29 (01) : 23 - 31
12345